Emerging markets & emerging needs: developing countries vaccine manufacturers' perspective & its current status

Biologicals. 2009 Jun;37(3):165-8. doi: 10.1016/j.biologicals.2009.02.009. Epub 2009 Mar 26.

Abstract

The success of vaccination has remained an important contribution towards public health in both industrialised and developing countries. However, there are still unmet public health needs in vaccine preventable diseases owing to issues related to affordability, supply, public awareness, research and development, intellectual property, skilled human resource, etc. Various global initiatives are being taken to tackle such issues. DCVMN, Developing Country Vaccine Manufacturers' Network, is one of such novel initiatives by developing countries, and is playing an important role in facilitating cheaper and quality vaccines to children of the world. DCVMN has become an international body for emerging vaccine manufacturers from the developing world. This manuscript provides an overview of DCVMN with respect to its origin, objectives, achievements, limitations and expectations.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Developing Countries
  • Health Services Needs and Demand*
  • Humans
  • Public Health
  • Vaccines*

Substances

  • Vaccines